Skip to content

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP

Seroprevalence of Anti-SARS-CoV2 Among Children According to Parents' SARS-CoV2 Serological Status. Study in a Hospital Population Assistance Publique-Hôpitaux Paris

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04442087
Acronym
FamilyPEDCOVID
Enrollment
563
Registered
2020-06-22
Start date
2020-06-19
Completion date
2021-04-30
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV2

Keywords

SARS-CoV2, COVID-19, Serology, Hospital workers, Children

Brief summary

The purpose of this study is to define seroprevalence of anti-SARS-CoV2 among children of Hospital Workers in APHP, particularly exposed population, according to parents' SARS-CoV2 serological status.

Interventions

BIOLOGICALSerology SARS-CoV2

Collect serum for Serology SARS-CoV2 at inclusion

BEHAVIORALData collection

Collect clinical and demographic data, habitus, Lifestyle Counseling at inclusion

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Hospital workers : 1. Individuals aged over 18, having a professional activity at the APHP (employees, interns, volunteers) 2. Affiliated to a social security regimen 3. Have at least one child under the age of 18 living in the same house. 4. have signed consent Child (ren), spouse and other member (s) residing at household: Child (ren), spouse and any other member residing in the household of a professional of the Paris Center Hospitals meeting the inclusion criteria above.

Exclusion criteria

Refuse to participate in research

Design outcomes

Primary

MeasureTime frameDescription
Seroprevalence of antibodies anti- SARS Cov2 in blood sample of children of Hospital workersat inclusionPercentage of children with seropositive in blood sample according to parents' SARS Cov2 serological status
Seroprevalence of antibodies anti- SARS Cov2 in saliva sample of children of Hospital workersat inclusionPercentage of children with seropositive according in saliva sample to parents' SARS Cov2 serological status

Secondary

MeasureTime frameDescription
Prevalence of different clinical symptoms in children with a positive serologyAt inclusion
Serological result of each member of the familyAt inclusion
Number of spouses of hospital workers with a positive serologyAt inclusion
Number of Asymptomatic Children with a positive seroloyAt inclusion
Number of severely symptomatic spouses of hospital workers with a positive serologyAt inclusion
Comparison of Serological result obtained in blood and saliva samplesAt inclusion
Risk factors based on a questionnaire for children and adultsAt inclusionthe following factors will be of particular importance: characteristics and composition of the family home, barrier measures, medical history and comorbidities.
Number of Asymptomatic spouses of hospital workers with a positive serologyAt inclusion
Number of severely symptomatic Children with a positive serologyAt inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026